Thiazoles Concept

subject area of

• A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis  Academic Article
• A Phase III Randomized Trial of the Timing of Meloxicam With Iodine-125 Prostate Brachytherapy  Academic Article
• A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers  Academic Article
• A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study  Academic Article
• A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients  Academic Article
• Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter Trial  Academic Article
• Actin Filaments Facilitate Insulin Activation of the Src and Collagen Homologous/Mitogen-activated Protein Kinase Pathway Leading to DNA Synthesis and c-fos Expression  Academic Article
• Advantages and limitations of the new anticoagulants  Academic Article
• Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049  Academic Article
• Analysis of the potency of various low molecular weight chemical chaperones to prevent protein aggregation  Academic Article
• Benzodiazepine-induced inhibition of human malignant melanoma (M-6) cell growth.  Academic Article
• Bicyclic thiazolidine lactam peptidomimetics of the dopamine receptor modulating peptide Pro-Leu-Gly-NH2  Academic Article
• Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation  Academic Article
• Bleeding and antidotes in new oral anticoagulants  Academic Article
• Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience  Academic Article
• Bleeding with direct oral anticoagulants vs warfarin: clinical experience  Academic Article
• Cholinergic Surveillance over Hippocampal RNA Metabolism and Alzheimer's-Like Pathology  Academic Article
• Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism  Academic Article
• Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study  Academic Article
• Clinical implications of reversal agents for direct oral anticoagulants  Academic Article
• Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors  Academic Article
• Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.  Academic Article
• Crosstalk between Notch and Sonic hedgehog signaling in a mouse model of amyotrophic lateral sclerosis  Academic Article
• Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenicE. coliis enhanced by TNF-α  Academic Article
• Design, Synthesis, and Dopamine Receptor Modulating Activity of Spiro Bicyclic Peptidomimetics of l-Prolyl-l-leucyl-glycinamide  Academic Article
• Detection and quantification of endoplasmic reticulum stress in living cells using the fluorescent compound, Thioflavin T  Academic Article
• Different binding sites for the neuropeptide Y Y1 antagonists 1229U91 and J-104870 on human Y1 receptors  Academic Article
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.  Academic Article
• Direct oral anticoagulants: evidence and unresolved issues  Academic Article
• Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism  Academic Article
• Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer’s disease  Academic Article
• Dyspepsia  Academic Article
• ENNOBLE-ATE trial: an open-label, randomised, multi-centre, observational study of edoxaban for children with cardiac diseases at risk of thromboembolism  Academic Article
• Edoxaban and amiodarone: interactions on multiple levels  Academic Article
• Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism  Academic Article
• Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer  Academic Article
• Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study  Academic Article
• Edoxaban for treatment of venous thromboembolism in patients with cancer  Academic Article
• Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial  Academic Article
• Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism  Academic Article
• Edoxaban versus Warfarin in Patients with Atrial Fibrillation  Academic Article
• Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial  Academic Article
• Effect of hyperthermia on liver cell lines: important findings for thermal therapy in hepatocellular carcinoma.  Academic Article
• Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs.  Academic Article
• Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6  Academic Article
• Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation  Academic Article
• Evolving use of new oral anticoagulants for treatment of venous thromboembolism  Academic Article
• Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study  Academic Article
• Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐ VTE Cancer study  Academic Article
• Factor Xa and thrombin as targets for new oral anticoagulants  Academic Article
• Gastrointestinal Bleeding With Edoxaban Versus Warfarin  Academic Article
• Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice  Academic Article
• Identification of Small Molecule Chemical Inhibitors of the Collagen-Specific Chaperone Hsp47  Academic Article
• Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial  Academic Article
• Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial  Academic Article
• Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry  Academic Article
• Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation  Academic Article
• Inhibition of Metabotropic Glutamate Receptor Signaling by the Huntingtin-binding Protein Optineurin  Academic Article
• Inhibition of Microsurgical Thrombosis by the Platelet Glycoprotein IIb/IIIa Antagonist SR121566A  Academic Article
• Inhibition of SREBP With Fatostatin Does Not Attenuate Early Diabetic Nephropathy in Male Mice  Academic Article
• International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants  Academic Article
• Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation  Academic Article
• Laboratory measurement of the direct oral anticoagulants  Academic Article
• Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial  Academic Article
• Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study  Academic Article
• Meloxicam selectively depresses the afterdischarge of rat spinal dorsal horn neurones in response to noxious stimulation  Academic Article
• Merging the potential of microbial genetics with biological and chemical diversity: an even brighter future for marine natural product drug discovery  Academic Article
• Molecular Coproscopy: Dung and Diet of the Extinct Ground Sloth Nothrotheriops shastensis  Academic Article
• Monitoring and reversal of direct oral anticoagulants  Academic Article
• NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank  Academic Article
• New Anticoagulants for Atrial Fibrillation  Academic Article
• New oral anticoagulant agents – general features and outcomes in subsets of patients  Academic Article
• New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions  Academic Article
• Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance  Academic Article
• Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism  Academic Article
• Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants  Academic Article
• Oral Direct Factor Xa Inhibitors  Academic Article
• Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease  Academic Article
• Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement  Academic Article
• Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study  Academic Article
• Overview of the New Oral Anticoagulants  Academic Article
• Oxidative Stress and Bioindicators of Reproductive Function in Pulp and Paper Mill Effluent Exposed White Sucker  Academic Article
• Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial  Academic Article
• Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy  Academic Article
• Possible Applications for Dopaminergic Agents Following Traumatic Brain Injury: Part 2  Academic Article
• Prokinetics for functional dyspepsia  Academic Article
• Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4–receptor antagonist cinalukast☆☆☆★  Academic Article
• Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation  Academic Article
• Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation  Academic Article
• Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study  Academic Article
• Regulation of kynurenine biosynthesis during influenza virus infection  Academic Article
• Reversal of Direct Oral Anticoagulants: Current Status and Future Directions  Academic Article
• Rheological blends for drug delivery. II. Prolongation of nerve blockade, biocompatibility, andin vitro-in vivocorrelations  Academic Article
• SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction  Academic Article
• SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis  Academic Article
• Selective cytotoxicity of gemcitabine in bladder cancer cell lines  Academic Article
• Sensory and vascular changes in a rat monoarthritis model: prophylactic and therapeutic effects of meloxicam  Academic Article
• Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment  Academic Article
• Spanish toxic oil syndrome: An isothiocyanate-derived compound cannot be substantiated as a causative agent  Academic Article
• Stroke prevention in AF: Of Asians and non-Asians  Academic Article
• Stroke prevention in atrial fibrillation: Closing the gap  Academic Article
• Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase  Academic Article
• Synthesis and Dopamine Receptor Modulating Activity of Substituted Bicyclic Thiazolidine Lactam Peptidomimetics of l-Prolyl-l-leucyl-glycinamide  Academic Article
• The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations  Academic Article
• Thiamin biosynthesis in Saccharomyces cerevisiae. Origin of carbon-2 of the thiazole moiety  Academic Article
• Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group.  Academic Article
• Validation of pH Dataloggers for Pharmacologic Studies  Academic Article
• Venous thromboembolism management: where do novel anticoagulants fit?  Academic Article